O'Brien ME - Search Results

1

Serum p53 antibodies: predictors of survival in small-cell lung cancer?

Murray PV, Soussi T, O'Brien ME, Smith IE, Brossault S, Norton A, Ashley S, Tavassoli M. Murray PV, et al. Br J Cancer. 2000 Dec;83(11):1418-24. doi: 10.1054/bjoc.2000.1475. Br J Cancer. 2000. PMID: 11076647 Free PMC article.

2

'VEEP' in children with Hodgkin's disease--a regimen to decrease late sequelae.

O'Brien ME, Pinkerton CR, Kingston J, Mott M, Tait D, Meller S, Radford M, Malpas J, McElwain TJ. O'Brien ME, et al. Br J Cancer. 1992 May;65(5):756-60. doi: 10.1038/bjc.1992.159. Br J Cancer. 1992. PMID: 1586603 Free PMC article. Clinical Trial.

3

Phase I study of mitozantrone, methotrexate and mitomycin with granulocyte colony-stimulating factor (filgrastim) in patients with advanced breast cancer.

O'Brien ME, Nicolson M, Montes A, Tidy A, Ashley S, Powles TJ. O'Brien ME, et al. Br J Cancer. 1994 Nov;70(5):980-3. doi: 10.1038/bjc.1994.433. Br J Cancer. 1994. PMID: 7524607 Free PMC article. Clinical Trial.

4

Aggressive management of doxorubicin-induced cardiomyopathy associated with 'low' doses of doxorubicin.

Sriskandan S, O'Brien ME, Smith IE, Collins P, Gore ME. Sriskandan S, et al. Postgrad Med J. 1994 Oct;70(828):759-61. doi: 10.1136/pgmj.70.828.759. Postgrad Med J. 1994. PMID: 7831179 Free PMC article.

5

Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer.

Powles TJ, Hickish TF, Makris A, Ashley SE, O'Brien ME, Tidy VA, Casey S, Nash AG, Sacks N, Cosgrove D, et al. Powles TJ, et al. J Clin Oncol. 1995 Mar;13(3):547-52. doi: 10.1200/JCO.1995.13.3.547. J Clin Oncol. 1995. PMID: 7884414 Clinical Trial.

6

The Royal Marsden Hospital pilot tamoxifen chemoprevention trial.

Powles TJ, Jones AL, Ashley SE, O'Brien ME, Tidy VA, Treleavan J, Cosgrove D, Nash AG, Sacks N, Baum M, et al. Powles TJ, et al. Breast Cancer Res Treat. 1994;31(1):73-82. doi: 10.1007/BF00689678. Breast Cancer Res Treat. 1994. PMID: 7981459 Clinical Trial.

7

Inefficacy of calcipotriol in skin metastases from breast cancer.

O'Brien ME, Talbot D, Maclennan K, Smith IE. O'Brien ME, et al. Lancet. 1993 Oct 16;342(8877):994. doi: 10.1016/0140-6736(93)92042-r. Lancet. 1993. PMID: 8105245 No abstract available.

8

Phase II study of continuous infusion fluorouracil with epirubicin and cisplatin in patients with metastatic and locally advanced breast cancer: an active new regimen.

Jones AL, Smith IE, O'Brien ME, Talbot D, Walsh G, Ramage F, Robertshaw H, Ashley S. Jones AL, et al. J Clin Oncol. 1994 Jun;12(6):1259-65. doi: 10.1200/JCO.1994.12.6.1259. J Clin Oncol. 1994. PMID: 8201387 Clinical Trial.

9

Carboplatin in the treatment of advanced breast cancer: a phase II study using a pharmacokinetically guided dose schedule.

O'Brien ME, Talbot DC, Smith IE. O'Brien ME, et al. J Clin Oncol. 1993 Nov;11(11):2112-7. doi: 10.1200/JCO.1993.11.11.2112. J Clin Oncol. 1993. PMID: 8229125 Clinical Trial.

10

A toxic interaction between mitomycin C and tamoxifen causing the haemolytic uraemic syndrome.

Montes A, Powles TJ, O'Brien ME, Ashley SE, Luckit J, Treleaven J. Montes A, et al. Eur J Cancer. 1993;29A(13):1854-7. doi: 10.1016/0959-8049(93)90537-p. Eur J Cancer. 1993. PMID: 8260241 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

311 results

Search Page

Filters